首页> 美国卫生研究院文献>Journal of Zhejiang University. Science. B >Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials
【2h】

Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials

机译:后置条件在原发性经皮冠状动脉介入治疗ST抬高型心肌梗死患者中的临床效果:一项随机对照试验的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To evaluate the clinical effect of postconditioning on patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). Methods: Randomized controlled trials were identified by searching relevant databases published up to April 2nd, 2014. A meta-analysis of eligible studies was performed by Stata 12.0 and Review Manager 5.2 with a fixed-effect model. Results: Ten studies providing adverse cardiac events in a total of 1346 STEMI patients treated with primary PCI were identified. The occurrence of heart failure was significantly reduced in patients treated with postconditioning compared with usual care (risk ratio (RR) 0.533; 95% confidence intervals (CI) 0.368–0.770), whereas non-fatal reinfarction slightly increased in the postconditioning group (RR 2.746; 95% CI 1.007–7.488). No significant difference in total major adverse cardiac events (MACEs) was observed between the two groups (RR 0.876; 95% CI 0.671–1.144). Conclusions: Postconditioning in STEMI patients undergoing primary PCI significantly reduces the risk of heart failure, but fails to decrease the incidence of total MACEs and the risk of non-fatal reinfarction.
机译:目的:评估后处理对原发性经皮冠状动脉介入治疗(PCI)治疗的ST段抬高型心肌梗死(STEMI)患者的临床效果。方法:通过搜索截至2014年4月2日发布的相关数据库来鉴定随机对照试验。由Stata 12.0和Review Manager 5.2使用固定效应模型对符合条件的研究进行荟萃分析。结果:共鉴定了10项研究,这些研究在总共1346例接受原发性PCI治疗的STEMI患者中提供了不良心脏事件。与常规护理相比,接受后处理的患者心力衰竭的发生率显着降低(风险比(RR)0.533; 95%置信区间(CI)0.368–0.770),而后处理组的非致命性再梗死略有增加(RR 2.746; 95%CI 1.007–7.488)。两组之间的总主要不良心脏事件(MACE)均无显着差异(RR 0.876; 95%CI 0.671–1.144)。结论:接受原发性PCI的STEMI患者的后处理可显着降低心力衰竭的风险,但不能降低总MACE的发生率和非致命性再梗死的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号